February 2019

– Patients Experienced a 77% Improvement in Aberrant Behaviors Associated with Social Avoidance Compared to Baseline after One Year of ZYN002 Treatment – – Presentation Today at the 57th Annual Meeting of the American College of Neuropsychopharmacology – DEVON, Pa., Dec. 12, 2018 (GLOBE NEWSWIRE) — , Inc. (NASDAQ:), the leader in innovative pharmaceutically-produced transdermal […]

by

We are comparing Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) and Intec Pharma Ltd. (NASDAQ:NTEC) on their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. They both are Biotechnology companies, competing one another. Earnings Valuation Table 1 shows the gross revenue, earnings per share and valuation for Diffusion Pharmaceuticals Inc. and Intec Pharma Ltd. Profitability Table […]

by

Greenleaf Trust decreased its stake in Gw Pharmaceuticals Plc Adr (GWPH) by 4.77% based on its latest 2018Q3 regulatory filing with the SEC. Greenleaf Trust sold 2,750 shares as the company’s stock declined 12.87% with the market. The institutional investor held 54,844 shares of the major pharmaceuticals company at the end of 2018Q3, valued at […]

by

KELOWNA, BC / ACCESSWIRE / February 21, 2019 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the ″Company″ or ″Lexaria″), a drug delivery platform innovator, is pleased to announce additional significant findings upon completion of further data analyses from its 2018 randomized, placebo-controlled, double-blinded European human clinical study that evaluated TurboCBD™, the Company’s proprietary, DehydraTECH™ […]

by

Abstract Attention-deficit/hyperactivity disorder (ADHD), once predominantly thought to be a disorder of childhood, is now recognized as commonly persisting into adulthood and the prime reproductive years. The author presents a case of a woman with a history of ADHD who is stable on stimulant therapy and presents for preconception counseling. The patient’s history is presented, […]

by

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) and GW Pharmaceuticals PLC (NASDAQ:GWPH) are both doing trailblazing work pushing clinical trials for cannabis-derived treatments that some pharma giants are too scared to undertake.   With pluck, these two companies are working on dazzling discoveries, designing cannabis-derived treatments that can help patients suffering rare epilepsies and neurological disorders.  “GW Pharmaceuticals has done […]

by

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions. … read more at: https://www.empr.com/home/news/drugs-in-the-pipeline/cannabidiol-gets-orphan-drug-status-for-preventing-ischemia-reperfusion-injury/

by

By AFPMore by this Author MONTREAL, When Canada legalises recreational bhang Wednesday, market watchers predict the birth of a new industry — creating thousands of jobs, investor euphoria, a new tax source for governments and maybe even tourism. Hundreds of licensed growers have sprouted in anticipation of the end of bhang prohibition, attracting major investment. […]

by

Washington State University researchers have seen cognitive changes in the offspring of rats exposed to heavy amounts of cannabis. Their work is one of the rare studies to look at the effects of cannabis during pregnancy. The drug is the most commonly used illicit substance among pregnant women. Ryan McLaughlin, an assistant professor of Integrative […]

by

Novelion Therapeutics Inc. (NASDAQ:NVLN) and Intec Pharma Ltd. (NASDAQ:NTEC), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation of the two firms. Earnings and Valuation Demonstrates Novelion Therapeutics Inc. and Intec Pharma Ltd. earnings per share […]

by

All you need to know, new report on “Cannabidiol Products Market by Application (Food Beverages, Pharmaceuticals, Cosmetics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” The Cannabidiol Products Market’s complete outline is crystal clear penned down in the global Cannabidiol Products Market research report such that not only an unskilled individual but also a professional can […]

by

Alzheimer’s Research UK has announced it will fund a pioneering clinical trial at King’s College London investigating a cannabis-based treatment for people living with dementia. Dementia, caused by diseases like Alzheimer’s, can cause a wide range of symptoms in people beyond memory loss, including loss of cognitive skills and behavioural changes. According to the charity, […]

by

Lexaria Bioscience Corp. (CSE:LXX, OTC:LXRP) (the “Company” or “Lexaria”), a drug delivery platform innovator, is pleased to announce additional significant findings upon completion of further data analyses from its 2018 randomized, placebo-controlled, double-blinded European human clinical study that evaluated TurboCBD(TM), the Company’s proprietary, DehydraTECH(TM) powered, cannabidiol (“CBD”) fortified hemp-oil capsule. Lexaria Bioscience Corp. (CSE:LXX, OTC:LXRP) (the […]

by